TARS logo

Tarsus Pharmaceuticals (TARS) EV/EBITDA

EV/EBITDA

-16.70
+0.06+0.36%

9 min ago


Summary


Performance

TARS EV/EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

OtherTARSvaluationmetrics:

EV/EBITDA Formula

EV/EBITDA =  
Enterprise Value
TTM EBITDA

TARS EV/EBITDA Trends

PeriodPeriodEV/EBITDAEV/EBITDAEnterprise valueEnterprise valuePricePrice
todaytoday+0.4%-0.3%-0.3%
1 m1 month+10.1%-10.0%-10.0%
3 m3 months-14.7%-3.4%-7.8%
6 m6 months-119.5%+62.7%+48.6%
ytdytd+15.1%-15.0%-14.9%
1 y1 year-130.7%+87.3%+53.9%
5 y5 years---

TARS EV/EBITDA Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month-11.2%-18.80+11.2%
3 m3-month-14.56-14.7%-20.42+18.2%
6 m6-month-7.44-124.5%-20.42+18.2%
1 y1-year-5.23-219.3%-20.42+18.2%
3 y3-year-2.25-642.2%-20.42+18.2%
5 y5-year-2.25-642.2%-126.62+86.8%
alltimeall time-2.25-642.2%-126.62+86.8%

Tarsus Pharmaceuticals EV/EBITDA History

DateValue
2025
-16.70(-15.1%)
2024
-19.66(+420.1%)
2023
-3.78(-34.8%)
DateValue
2022
-5.80(-75.5%)
2021
-23.65(-5.4%)
2020
-25.00

FAQ

  • What is Tarsus Pharmaceuticals EV/EBITDA?
  • What is the all time high EV/EBITDA for Tarsus Pharmaceuticals?
  • What is TARS EV/EBITDA year-to-date change?
  • What is Tarsus Pharmaceuticals EV/EBITDA year-on-year change?

What is Tarsus Pharmaceuticals EV/EBITDA?

The current EV/EBITDA of TARS is -16.70

What is the all time high EV/EBITDA for Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals all-time high EV/EBITDA is -2.25

What is TARS EV/EBITDA year-to-date change?

Tarsus Pharmaceuticals EV/EBITDA has changed by +2.96 (+15.06%) since the beginning of the year

What is Tarsus Pharmaceuticals EV/EBITDA year-on-year change?

Over the past year, TARS EV/EBITDA has changed by -9.46 (-130.66%)